Business Context and Reporting Period
This Form 8-K Current Report was filed by National HealthCare Corporation (NHC) on November 12, 2025, regarding events occurring on November 6, 2025. The filing addresses significant changes to the Company's Board of Directors and executive leadership structure.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Board Appointment: Dr. Lisa Piercey was appointed as a Class 1 Director and to the Audit Committee, effective November 6, 2025. She is an independent director with a background in healthcare investment and state health administration.
- Executive Leadership Transition: R. Michael Ussery, President and Chief Operating Officer, will retire effective December 31, 2025.
- Role Consolidation: Stephen F. Flatt, current CEO, will assume the additional title of President effective immediately upon Mr. Ussery's retirement.
- Operational Leadership: Timothy J. Shelly, SVP Operations, will assume the role of principal operating officer following Mr. Ussery's retirement, retaining his current title.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of material risks and contingencies. Regarding compensation, the Company stated that no changes to the compensation of Dr. Flatt or Mr. Shelly have been approved at this time, and the Company does not currently have employment agreements with its executive officers.
Investor Verification Checklist
- Verify the specific terms of Dr. Lisa Piercey's director compensation in the 2025 Proxy Statement.
- Confirm the transition timeline for R. Michael Ussery's retirement on December 31, 2025.
- Review the 2025 Proxy Statement for biographical details on Stephen F. Flatt and Timothy J. Shelly.
- Monitor future filings for any new employment agreements or compensation adjustments for the newly appointed officers.